Literature DB >> 26862189

Recent structural and mechanistic insights into protein O-GalNAc glycosylation.

Ramon Hurtado-Guerrero1.   

Abstract

Protein O-GalNAcylation is an abundant post-translational modification and predicted to occur in over 80% of the proteins passing through the Golgi apparatus. This modification is driven by 20 polypeptide GaINAc (N-acetylgalactosamine)-transferases (GalNAc-Ts), which are unique in that they possess both catalytic and lectin domains. The peptide substrate specificities of GalNAc-Ts are still poorly defined and our understanding of the sequence and structural features that direct O-glycosylation of proteins is limited. Part of this may be attributed to the complex regulation by coordinated action of multiple GalNAc-T isoforms, and part of this may also be attributed to the two functional domains of GalNAc-Ts that both seems to be involved in directing the substrate specificities. Recent studies have resulted in 3D structures of GalNAc-Ts and determination of the reaction mechanism of this family of enzymes. Key advances include the trapping of binary/ternary complexes in combination with computational simulations and AFM/small-SAXS experiments, which have allowed for the dissection of the reaction coordinates and the mechanism by which the lectin domains modulate the glycosylation. These studies not only broaden our knowledge of the modes-of-action of this family of enzymes but also open up potential avenues for the rational design of effective and selective inhibitors of O-glycosylation.
© 2016 Authors; published by Portland Press Limited.

Entities:  

Keywords:  GalNAc-Ts; enzyme dynamics; flexible linker; lectin domain; retention mechanism; structural biology

Mesh:

Substances:

Year:  2016        PMID: 26862189     DOI: 10.1042/BST20150178

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  6 in total

1.  Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3.

Authors:  Matilde de Las Rivas; Earnest James Paul Daniel; Yoshiki Narimatsu; Ismael Compañón; Kentaro Kato; Pablo Hermosilla; Aurélien Thureau; Laura Ceballos-Laita; Helena Coelho; Pau Bernadó; Filipa Marcelo; Lars Hansen; Ryota Maeda; Anabel Lostao; Francisco Corzana; Henrik Clausen; Thomas A Gerken; Ramon Hurtado-Guerrero
Journal:  Nat Chem Biol       Date:  2020-01-13       Impact factor: 15.040

Review 2.  Emerging structural insights into glycosyltransferase-mediated synthesis of glycans.

Authors:  Kelley W Moremen; Robert S Haltiwanger
Journal:  Nat Chem Biol       Date:  2019-08-19       Impact factor: 15.040

3.  GlycoMinestruct: a new bioinformatics tool for highly accurate mapping of the human N-linked and O-linked glycoproteomes by incorporating structural features.

Authors:  Fuyi Li; Chen Li; Jerico Revote; Yang Zhang; Geoffrey I Webb; Jian Li; Jiangning Song; Trevor Lithgow
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

4.  Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitate.

Authors:  John R Haserick; Joshua A Klein; Catherine E Costello; John Samuelson
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

5.  The interdomain flexible linker of the polypeptide GalNAc transferases dictates their long-range glycosylation preferences.

Authors:  Matilde de Las Rivas; Erandi Lira-Navarrete; Earnest James Paul Daniel; Ismael Compañón; Helena Coelho; Ana Diniz; Jesús Jiménez-Barbero; Jesús M Peregrina; Henrik Clausen; Francisco Corzana; Filipa Marcelo; Gonzalo Jiménez-Osés; Thomas A Gerken; Ramon Hurtado-Guerrero
Journal:  Nat Commun       Date:  2017-12-05       Impact factor: 14.919

6.  Structural basis for the synthesis of the core 1 structure by C1GalT1.

Authors:  Ana Sofia Grosso; Zhang Yang; Ismael Compañón; Helena Coelho; Andrés Manuel González-Ramírez; Yoshiki Narimatsu; Henrik Clausen; Filipa Marcelo; Francisco Corzana; Ramon Hurtado-Guerrero
Journal:  Nat Commun       Date:  2022-05-03       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.